Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Gyrodyne LLC (GYRO) Stock Forecast & Price Prediction United States | NASDAQ | Real Estate | Real Estate Services
$7.99
+0.00 (0.00%)Did GYRO Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Gyrodyne is one of their latest high-conviction picks.
GYRO has shown a year-to-date change of -13.5% and a 1-year change of 3.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for GYRO. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for GYRO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Gyrodyne based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Gyrodyne LLC has a market capitalization of $17.57M with a P/E ratio of 47.8x. The company generates $2.74M in trailing twelve-month revenue with a -137.1% profit margin.
Revenue growth is -1.8% quarter-over-quarter, while maintaining an operating margin of -121.3% and return on equity of N/A.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Real estate ownership, development, and management.
Gyrodyne LLC makes money through leasing commercial and industrial properties, particularly in the medical and healthcare sectors. The company enhances its portfolio by actively pursuing development and redevelopment projects, as well as managing land entitlement and zoning transformations to increase property value and utility.
With a history in engineering and manufacturing, Gyrodyne has strategically shifted its focus to real estate, targeting niche markets and providing specialized solutions for tenant needs. This adaptability allows the company to respond effectively to market demands and contributes to its growth in the real estate investment sector.
Real Estate
Real Estate Services
6
Mr. Gary Jay Fitlin
United States
1995
Star Equity has agreed to reduce its board size and implement limitations on director compensation, while also withdrawing its nominations for board positions.
Board size reduction and compensation limitations may enhance governance and efficiency, potentially improving company performance and investor confidence. Withdrawal of nominations signals stability.
Gyrodyne, LLC (NASDAQ:GYRO) announced the sale of approximately 49 acres of vacant land in St. James, NY, to B2K Smithtown LLC through its subsidiary, GSD Flowerfield, LLC.
The sale of 49 acres by Gyrodyne could enhance cash flow and reduce holding costs, potentially boosting investor confidence and impacting the company's stock performance.
Gyrodyne, LLC (NASDAQ: GYRO) received a favorable ruling from the New York Supreme Court, dismissing a petition against its subdivision approval for the Flowerfield property.
The Supreme Court ruling supports Gyrodyne's development plans, potentially increasing the company's asset value and boosting investor confidence in future growth prospects.
Gyrodyne, LLC (NASDAQ: GYRO) closed its rights offering, selling 625,000 Common Shares at $8 each, raising $5 million gross ($4.4 million net) for the company.
Gyrodyne's successful rights offering indicates strong investor confidence, raising $5 million to enhance liquidity and potentially fund growth initiatives, positively impacting future valuations.
Gyrodyne, LLC (NASDAQ: GYRO) has begun the subscription period for its rights offering, aimed at raising capital for its diversified real estate portfolio.
Gyrodyne's rights offering indicates potential dilution of shares, impacting stock value. It also reflects the company's strategy to raise capital, which may affect future growth and investor returns.
Gyrodyne, LLC (NASDAQ: GYRO) has set January 29, 2024, at 5:00 p.m. ET as the record date for its upcoming rights offering.
Gyrodyne's upcoming rights offering can impact stock dilution and capital raising, influencing investor sentiment and potential share value on the record date.
Analyst forecasts for Gyrodyne LLC (GYRO) are not currently available. The stock is trading at $7.99.
Analyst ratings for GYRO are not currently available. The stock is currently trading at $7.99. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for GYRO are not currently available. The stock is trading at $7.99.
Gyrodyne LLC makes money through leasing commercial and industrial properties, particularly in the medical and healthcare sectors. The company enhances its portfolio by actively pursuing development and redevelopment projects, as well as managing land entitlement and zoning transformations to increase property value and utility.
Price targets from Wall Street analysts for GYRO are not currently available. The stock is trading at $7.99.
Price targets from Wall Street analysts for GYRO are not currently available. The stock is trading at $7.99.
Analyst ratings for GYRO are not currently available. The stock is trading at $7.99.
Stock price projections, including those for Gyrodyne LLC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.